Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preoperative pulmonary evaluation.

C V Jackson1

  • 1Division of Pulmonary Medicine, US Air Force Medical Center, Lackland Air Force Base, Tex.

Archives of Internal Medicine
|October 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological profile of recombinant, human activated protein C (LY203638) in a canine model of coronary artery thrombosis.

The Journal of pharmacology and experimental therapeutics·2000
Same author

Intravenous administration of the glycoprotein IIb-IIIa receptor antagonist 7E3 induces reperfusion of an acute thrombotic occlusion of the canine coronary artery.

Thrombosis research·1998
Same author

Antithrombotic assessment of the effects of combination therapy with the anticoagulants efegatran and heparin and the glycoprotein IIb-IIIa platelet receptor antagonist 7E3 in a canine model of coronary artery thrombosis.

Circulation·1996
Same author

A family of arginal thrombin inhibitors related to efegatran.

Seminars in thrombosis and hemostasis·1996
Same author

Reversible tripeptide thrombin inhibitors as adjunctive agents to coronary thrombolysis: a comparison with heparin in a canine model of coronary artery thrombosis.

Journal of cardiovascular pharmacology·1993
Same author

Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.

The Journal of pharmacology and experimental therapeutics·1992
Same journal

Elevated CK-MB With Normal Total Creatine Kinase Levels in Patients Undergoing Maintenance Hemodialysis-Reply.

Archives of internal medicine·2017
Same journal

Occult Carbon Monoxide Poisoning-Reply.

Archives of internal medicine·2017
Same journal

Acquired Immune Deficiency Syndrome-Reply.

Archives of internal medicine·2017
Same journal

Heparin Side Effects-Reply.

Archives of internal medicine·2017
Same journal

Humanizing primary care medicine begins with stress.

Archives of internal medicine·2017
Same journal

Legend omitted and number misrepresented.

Archives of internal medicine·2013
See all related articles

Identifying patients at high risk for perioperative pulmonary complications is crucial. Key risk factors include obstructive lung disease and hypercapnia, guiding preventative strategies for better surgical outcomes.

Area of Science:

  • Pulmonary Medicine
  • Anesthesiology
  • Thoracic Surgery

Background:

  • Perioperative pulmonary complications pose significant risks to surgical patients.
  • Several factors, including obstructive lung disease, smoking, obesity, and prolonged anesthesia, are associated with increased risk.
  • Hypercapnia is a consistent indicator of high perioperative risk.

Purpose of the Study:

  • To identify key risk factors for perioperative pulmonary complications.
  • To evaluate anesthetic techniques and risk stratification for lung resection surgery.
  • To outline preventative strategies for high-risk patients, particularly those with chronic obstructive pulmonary disease.

Main Methods:

  • Review of factors contributing to perioperative pulmonary complications.

Related Experiment Videos

  • Comparison of spinal versus general anesthesia for pulmonary complication risk.
  • Assessment of high-risk indicators for lung resection, including pulmonary function tests and clinical signs.
  • Evaluation of preoperative interventions and prophylactic measures.

    • Main Results:

    • Obstructive lung disease, smoking history with productive cough, obesity, and prolonged anesthesia are significant risk factors.
    • Hypercapnia consistently indicates high risk.
    • No difference in pulmonary complication risk was observed between spinal and general anesthesia.
    • For lung resection, low predicted postoperative forced expiratory volume in one second (<1000 mL), hypercapnia, severe dyspnea, and advanced age with cardiopulmonary disease are high-risk indicators.

    Conclusions:

    • Preoperative risk assessment is vital for identifying patients susceptible to pulmonary complications.
    • Discontinuation of smoking at least eight weeks prior and pulmonary toilet are essential for COPD patients.
    • Prophylactic lung expansion maneuvers can reduce postoperative atelectasis in high-risk individuals.